BioNexus Gene Lab Income Taxes 2019-2024 | BGLC
BioNexus Gene Lab income taxes from 2019 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
| BioNexus Gene Lab Annual Income Taxes (Millions of US $) |
|
|---|---|
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $-0 |
| 2018 | $0 |
| BioNexus Gene Lab Quarterly Income Taxes (Millions of US $) |
|
|---|---|
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $-0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $-0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $-0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $-0 |
| 2019-12-31 | $-0 |
| 2019-09-30 | $-0 |
| 2019-06-30 | $-0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.006B | $0.010B |
| BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $95.766B | 11.88 |
| Cencora (COR) | United States | $49.023B | 18.08 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| ICON (ICLR) | Ireland | $17.511B | 15.60 |
| Natera (NTRA) | United States | $16.712B | 0.00 |
| Viatris (VTRS) | United States | $15.433B | 4.75 |
| Avantor (AVTR) | United States | $14.831B | 22.24 |
| Revvity (RVTY) | United States | $14.647B | 25.44 |
| BioMerieux (BMXMF) | France | $12.894B | 0.00 |
| CochLear (CHEOY) | Australia | $12.739B | 0.00 |
| Solventum (SOLV) | United States | $12.214B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.215B | 31.59 |
| Charles River Laboratories (CRL) | United States | $11.042B | 21.34 |
| Doximity (DOCS) | United States | $10.778B | 63.79 |
| HealthEquity (HQY) | United States | $8.750B | 47.49 |
| Sonic Healthcare (SKHHY) | Australia | $8.450B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.881B | 32.03 |
| Life Times (LTH) | United States | $5.005B | 33.12 |
| Sotera Health (SHC) | United States | $4.402B | 23.55 |
| Organon (OGN) | United States | $4.012B | 4.05 |
| Surgery Partners (SGRY) | United States | $3.759B | 42.85 |
| BrightSpring Health Services (BTSG) | United States | $3.402B | 72.37 |
| PACS (PACS) | United States | $3.129B | 0.00 |
| Concentras Parent (CON) | United States | $2.579B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.523B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.446B | 0.00 |
| Premier (PINC) | United States | $2.301B | 11.48 |
| GeneDx Holdings (WGS) | United States | $2.113B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.783B | 47.00 |
| Teladoc Health (TDOC) | United States | $1.670B | 0.00 |
| Progyny (PGNY) | United States | $1.551B | 29.62 |
| Pediatrix Medical (MD) | United States | $1.331B | 13.02 |
| CareDx (CDNA) | United States | $1.251B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
| Embecta (EMBC) | United States | $0.898B | 5.99 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| InnovAge Holding (INNV) | United States | $0.778B | 0.00 |
| Agilon Health (AGL) | United States | $0.770B | 0.00 |
| SBC Medicals (SBC) | United States | $0.717B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.442B | 0.00 |
| DocGo (DCGO) | United States | $0.426B | 16.00 |
| Enhabit (EHAB) | United States | $0.383B | 33.09 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.346B | 0.00 |
| LifeMD (LFMD) | United States | $0.310B | 0.00 |
| ModivCare (MODV) | United States | $0.244B | 13.24 |
| Sera Prognostics (SERA) | United States | $0.242B | 0.00 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Nutex Health (NUTX) | United States | $0.204B | 0.00 |
| Biodesix (BDSX) | United States | $0.204B | 0.00 |
| MultiPlan (MPLN) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.120B | 0.00 |
| So-Young (SY) | China | $0.073B | 17.77 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.12 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |